Skip to content

Cold Magnesium Sulfate Solution for Perineal Swelling Following Vaginal Delivery

Comparison Between Treatment With Gauze Soaked With Cold Magnesium Sulfate Solution Against Gauze Soaked With Cold Water for Treatment of Perineal Swelling Following Vaginal Delivery - A Double Blind Placebo Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02024256
Acronym
MgSo4
Enrollment
206
Registered
2013-12-31
Start date
2014-01-31
Completion date
Unknown
Last updated
2016-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perineal Pain, Perineal Swelling, Vaginal Delivery

Keywords

Vaginal delivery, Perineal swelling, Perineal pain, MgSo4, Magnesium sulfate, Cold water

Brief summary

The purpose of this study is to compare the impact of treatment with cooled magnesium sulfate and cold water-soaked pads on perineal pain and swelling following vaginal delivery. Assessment of appropriateness for each patient to take part in the study will be performed approximately 2 hours following delivery. Those patients who consent to participate in the trial will be allocated to treatment groups in a double-blinded, randomized manner. Women in the study group will receive treatment with pads soaked in a cold aqueous solution of magnesium sulfate at 33% (w/v) concentration, while those in the control group will receive treatment with pads soaked in cold water. Nurses will initiate treatment according to the group to which the patient was randomized. Said pads will be given the patients routinely 5 times a day at regular times. A physician will assess the perineal swelling according to visual (photographed) scale in which severe, moderate, light and no swelling will be defined. Measurement of swelling in centimeters (maximal length and breadth); photography, by a medical photographer or the examining doctor, of the perineal area with a centimeter ruler, before, during and after treatment (photography is dependent on patient approval and is not a precondition to participation in the trial.); and additional examination, on the above basis, will be performed regarding hemorrhoids in the event that a patient has complained of such. A nurse will assess the perineal pain and swelling on a scale ranging from 0 to 10 prior to the patient being given the pad and an hour following treatment. An additional assessment by the same method will be performed regarding hemorrhoid pain. Any analgesia administered will also be recorded. Likewise, for follow-up purposes a blood test for serum magnesium concentration will be taken before and after treatment. Period of follow-up will be 48-72 hours from childbirth.

Interventions

OTHERCold pads soaked in Magnesium sulfate solution
OTHERCold pads soaked in water

Sponsors

HaEmek Medical Center, Israel
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* parturients following normal vaginal birth or vacuum-assisted vaginal delivery * reporting of perineal pain equal to or greater than 3 on a 0-10 scale

Exclusion criteria

* parturients following cesarean section * lack of consent to take part in the study * parturients interested in early discharge (within 48 hours of childbirth) * girls under 18 years of age

Design outcomes

Primary

MeasureTime frame
Reduction in the level of perineal pain3 days
Reduction in perineal swelling3 days

Secondary

MeasureTime frame
Reduction in hemorrhoids pain and swelling3 days

Countries

Israel

Contacts

Primary ContactZohar Nahum, MD
nachum_zo@clalit.org.il97246494158
Backup ContactIrit Friedman, MA
iritdavid@gmail.com, irit_da@clalit.org.il972546202261

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026